Amcor, a global leader in developing and producing a diverse offering of responsible packaging solutions, today annou

In a context of full-scale sorting and recycling infrastructure, Gualapack’s first-ever monomaterial polypropylene sp

These corrugated boxes refer to used containers or packaging made from unbleached, unwaxed paper with ruffled (‘corru

AMI, Bristol, 17/08/21 Cast PP Films – The European Market 2021, is a brand new report from leading plastics market intelligence providers, AMI. The company has leveraged its expertise and proven methodology in other consumer and industrial films, to complete this new study for 2021. The report provides critical insight and analysis of the production, capacity and demand of Cast Polypropylene (CPP) film in Europe, together with trends in key consumer and industrial applications.

Demand for Cast PP films continues to grow. The heat resistant properties of the film are invaluable to food packaging converters as well as those catering to the medical and healthcare market, sectors which have proven themselves to be Covid-19 resilient industries.

The Covid-19 pandemic also caused consumers to become more concerned with sterility and safety of their products, choosing sealed products other unpackaged, or those with loose wrapping. This stalled the “less plastic packaging” trend although this is expected to pick up as sustainability comes back to the fore.

Although Cast PP film is used worldwide, the market in Europe is of particular interest, being at the forefront of the drive to sustainability and the circular economy. Amid tightening regulations on recycling and surging media and public concern around plastic litter, companies across the plastics value chain are investigating how to mitigate this potential threat to the plastic films sector. Cast PP films can be utilised in polyolefin-based monomaterial “recycle-ready” film constructions, making it a go-to film for many packaging applications, and spurring future growth opportunities.

The study explores the variety of different properties that Cast PP films can offer the end-user, and the trends which differ by application. Each of these properties and more, is explored by end-use sector, whether in food packaging, non-food packaging or other technical applications.

New manufacturing techniques are providing further options for versatility, and many Cast PP film lines confirmed for future production are earmarked for capacity expansion or upgrading to improve speed and efficiency.

There is still a West/East divide in terms of packaging use. Cast PP production is growing in new geographic locations, which will prompt a change in trade flows.

Consumer trend analysts at Spate recently noted that the search volume for “sunscreen” has increased 30.8% year-over-

Agreement gives Aptar Pharma an exclusive 12-month option to acquire worldwide rights to Pharmaxis’ proprietary “Orbital” technology, which delivers large payloads of drug in a convenient, easy-to-use format

Crystal Lake, Illinois, August 17, 2021 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that they have entered into an agreement with Pharmaxis, a clinical stage drug developer, under which Aptar Pharma has the option to acquire the worldwide rights to Pharmaxis’ proprietary high payload dry powder inhaler, Orbital. As part of the agreement, Aptar Pharma will evaluate the commercial applications for the Orbital device and further develop the prototype device to meet unmet market needs. Pharmaxis retains the rights to devices containing Orbital intellectual property used to deliver inhaled mannitol.

The Orbital technology is built on Pharmaxis patents, which allow powder payloads of up to 400mg or more to be inhaled by patients in divided doses without the need to reload. This unique platform was originally developed as a life cycle extending product for the Pharmaxis cystic fibrosis drug Bronchitol®. However, it also meets an increasing global need to deliver high doses of other drugs, such as antibiotics, to the lungs.

Howard Burnett, Vice President Global Pulmonary Category, Aptar Pharma commented, “We are pleased to partner with Pharmaxis on this novel technology, which continues the development of Aptar Pharma’s industry-leading portfolio of devices for inhalation. Coupled with our broad Aptar Pharma Services offering, we will seek to expand the range of drugs administered by inhalation.”

“I am delighted with the forthcoming partnership with Aptar Pharma, who are one of the world’s foremost drug delivery device companies. In their hands, we hope to fully exploit the potential of the Orbital technology in other drugs and secure a return on the work we have already completed,” commented Pharmaxis CEO Gary Phillips. “The Orbital Inhaler is an innovative new device that eliminates the need for manual reloading of multiple powdercontaining capsules needed for a single dose of drug. This can deliver improvements in the patient experience, compliance, market share and also effectively extend patent life of drugs that use the device.”

About Pharmaxis Pharmaxis Ltd is an Australian clinical stage drug development company developing drugs for inflammatory and fibrotic diseases, with a focus on myelofibrosis. The company has a highly productive drug discovery engine built on its expertise in the chemistry of amine oxidase inhibitors, with drug candidates in clinical trials. Pharmaxis has also developed two respiratory products which are approved and supplied in global markets, generating ongoing revenue. Pharmaxis is listed on the Australian Securities Exchange (PXS). Its head office, manufacturing and research facilities are in Sydney, Australia. www.pharmaxis.com.au.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Global aerosol dispensing company, LINDAL Group has introduced an advanced spray imaging system to help deliver new levels of spray performance insight for customers.

As market-leading dispensing experts, LINDAL already conduct detailed spray analysis in the form of flow, particle size, spray angle/shape and spray pattern performance on their standard product range, as well as the bespoke solutions they work on with their innovation partners. The new technology not only adds to this, but provides a new avenue for in-depth consumer tests, with additional spray characterisations, including the measurement of shape and velocity also planned for the future utilisation of the technology.

The new measurement technology, deployed at LINDAL’s Global Innovation Centre in France, uses optical techniques to capture spray behaviour at high speed (around 7500 images per second). Comprising of front and back radial lighting, camera and suction system hardware, its integrated software produces 30 second videos of spray movement for analysis, equivalent to 0.1 seconds in real time. The process provides detailed information on axial plume spray, including the particle distribution as well as the angle, diameter and length.

Eric Lambine, Central Laboratory Manager at LINDAL’s GIC, said: “The software’s ability to capture the behaviour of the spray and not simply the size of spray particles, is crucial. This information allows us to understand so much more about spray patterns and performance, which creates far greater objectivity to our analyses and discussions. We believe it will significantly benefit our customers that we are working with now and in the future.”

The company believes the spray imaging system will also be effective when testing compressed air dispensing solutions. Spray performance can be affected due to a reduction of pressure over the lifecycle of the can, resulting in a larger droplet sizes and a ‘wet’ final product, not suitable for products such as hairsprays and deodorants.

With the production of more in-depth spray performance data, LINDAL plans to use the technology with compressed air systems to greater understand the performance of the product in association with the valve and actuator combination, over the lifecycle of a can.

Eric says: “We aim to generate a template incorporating an optimum propellant, valve and actuator combination, as well as deriving further quantitative data, producing new levels of quality in all our dispensing systems. Our ultimate goal is to give our customers the best opportunity to provide an improved consumer experience.”

About LINDAL Group
LINDAL Group is a worldwide leader in the design, manufacture and sale of valves, actuators and spray caps used in aerosol products. The Hamburg, Germany-based company has more than 60 years of experience with innovative dispensing solutions for the cosmetics, household, pharmaceuticals, food and technical industries.

The LINDAL Group is represented by subsidiaries and licensees in more than 15 countries throughout Europe, Asia and The Americas. The company is renowned for its innovative designs, which deliver optimal functionality and return on investment. As a result, LINDAL packaging solutions are the choice of the world’s most prestigious and trusted brands.

For more information, please contact: marketing@lindalgroup.com.

Although wine is, of course, a traditional market in Italy, it has great potential for innovation.

Eco for Life bottles are made 100% from plants and filled with finest spring water  bottled at source in locations ac

Berry Bramlage has won German Packaging Awards in the Sustainability category for significant design and technical enhancements to two packaging solutions. Two years after the Berry Global acquisition of RPC, the combined expertise of these two packaging leaders is paying off with continued sustainability innovation.

The Lip Care stick and Magic Star Light were praised by the judging panel for their move to a mono-material pack, which both improves recyclability and reduces their weight, while maintaining full functionality and consumer convenience.

The design of the Lip Care stick has been optimised from a 4-part assembly with a polyoxymethylene (POM) piston to a 3-part version with a polypropylene (PP) piston. As well as being easier to recycle thanks to all components now being made from PP, the new 3-part construction is lighter than its previous generation.

At the same time, the stick can be specified in two versions, with a 2.5 turn for a slow opening and a 0.75 turn for a faster opening, both of which ensure precise control to avoid any breaking of the lipstick or balm.

The Magic Star Light has similarly replaced a metal spring in the dispenser head with a PP version, which has been developed and produced as a mono-material pack. This has resulted in a significant weight reduction for the new all-plastic package.

These enhancements have been achieved while maintaining the existing benefits of the Magic Star design, which ensures accurate and controlled dispensing of even the most viscous creams with up to 96% residual emptying, whilst also providing protection of sensitive formulae from oxygen ingress.

“As a leader in design for circularity, we are delighted to win these prestigious awards,” commented Thierry Bernet, Circular Economy Director for Berry. “They are a fitting endorsement of our commitment to develop packs that maximise the many benefits of plastics while minimising their impact on the environment.”

Organised by the German Packaging Institute (DVI), the German Packaging Awards are Europe’s largest showcase of packaging achievements. This year a total of 52 innovations from six countries have been recognised. The awards will be presented at Fachpack in September.

“We have been observing take-away coffee aficionados and have focused on developing innovative sustainable packaging

New technology by Hiperbaric, the world’s leading company specialising in industrial equipment for High Pressure Tech

They are optimally tailored to the respective product and interfere with the environment as little as possible. At th

Over the last twelve years, Big Marble Farms has grown from 5 to 55 acres.

Chevigny-Saint-Sauveur, France, 5 August 2021 – Benvic announces the acquisition of the US-based Chemres, a leading provider of polymers, custom compounds and solutions for a variety of industries including medical, packaging, wire & cable.

Headquartered in Princeton (New Jersey) and with operations in Chesapeake (Virginia), Chemres is a specialty compounder with a strong position in the US contact lens market and it also has long-term customer relationships in the medical, wire & cable, and packaging industries. The company provides a high level of dedicated customer service as well as logistical and supply chain management expertise.

The combination with Chemres will allow Benvic to enter the US market and strengthen its exposure to the medical sector, allowing Benvic to become a key global supplier in this market. Benvic will combine its track record of supplying highly innovative solutions with the expertise of Chemres in the North American marketplace and its strong customer portfolio. The acquisition of Chemres is the ninth ‘add-on’ acquisition since Benvic joined Investindustrial’s portfolio in 2018. Among the others, in 2019 Benvic acquired Modenplast Medical, an Italian compounder, specialising in medical grade vinyl compounds and tubing extrusion. This was followed in 2020 with the acquisition of Luc & Bel, an Italian manufacturer which specializes in the design and manufacture of medical device components, and in 2021 with the acquisition of selected TPE and PP compounding assets from Celanese.

The management team of Chemres, led by Chemres’ founder Paul Keimig, are partnering with Benvic to lead Benvic’s growth in North America.

Luc Mertens, CEO of Benvic Group, said: “like Benvic, Chemres is a top performer in the compounding industry; out-performing competitors in growth, quality and client satisfaction. Our shared culture for performance and innovation will enable us to develop new business and technical synergies, and provide us with an exciting strategic opportunity in the US market. We look forward to work closely with the management team of Chemres in the coming years to expand our operations in North America and grow our polymer expertise across sectors and in particular in the medical sector. This acquisition is an important step forward in Benvic becoming a global leader in compounding."

Paul Keimig, CEO of Chemres, said: “Chemres is excited to partner with Benvic in order to accelerate our growth as well as provide additional value for our customers. Benvic’s proven success in similar markets and the desire to use Chemres to grow its portfolio in the US market was key in our decision making process. With Benvic’s vision to be the global leader, Chemres will accelerate its growth through organic and additional compounding acquisitions in the US market. Together, Benvic Group, through Chemres, will have unparalleled, global capabilities in the compounding world.”

About Benvic Group Founded in 1963 and a portfolio company of Investindustrial since 2018, Benvic Group is one of the leading suppliers of thermoplastic solutions in Europe. From idea to realisation for its customers, Benvic develops, manufactures and markets innovative and highly customised thermoplastic solutions that are used in a wide range of applications, namely construction, medical, automotive, fluid transport, electro technical products, cables and food. Benvic has around 470 employees and currently operates a total of 8 production sites in France, Italy, Spain, Poland and UK. The group now exports to over 60 countries worldwide. Further information available at www.benvic.com

About Chemres Headquartered in Princeton, NJ, Chemres is a global supplier of commodity and engineering resins. For nearly 25 years, Chemres has been servicing the medical, packaging and wire & cable markets using multiple manufacturing technologies. The company’s ISO 13485:2016 compounding facility in Chesapeake, VA has recently added capacity to support the growing demand. Located near the Norfolk International Terminals (NIT), the site offers easy access for imports/exports and transfer of material from sea containers to railcar, bulk truck and various packaging options.

The latest office will form part of Xaar’s global network and provide support to its growing Chinese OEM and partner

The new packages each feature a piece of artwork drawn by various CMN Hospitals Champions, who are child ambassadors

The development of the aluminum tubes and aerosol can market in the first half of 2021 can only be adequately assessed for the German market in retrospect to 2020 because the first quarter of 2020 at the beginning of the COVID-19 crisis was still characterized by extremely lively demand from all end consumer markets.

Food and household sectors stable in the crisis, pharmaceuticals mixed, cosmetics weaker

In the course of the crisis, however, deliveries to the cosmetics market, which dominates in terms of volume, declined significantly due to mobility restrictions and temporary closures of hairdressing salons, beauty and care studios and duty-free shops in airports. The demand for deodorants and hair colours fell noticeably, with the hair colour segment weakening particularly in the first quarter of 2021.

Deliveries to the food and household sectors even went up significantly against the trend during this period. In contrast, demand from the pharmaceutical market was mixed because drug prescriptions went down due to the decline in doctor visits during the pandemic.

In view of these pandemic-related developments, the total decrease in deliveries in the industry which amounted to 7 percent in the first half of 2021 is still moderate.

Reliability of aluminum packaging manufacturers in difficult times

Customers' plans are still extremely short-term and volatile, which demands a high degree of flexibility in production planning from packaging manufacturers. The tube and aerosol can industry is worried about the still unusually high prices for raw materials such as aluminum, plastic, cardboard, wood, coatings, printing inks and for transport services, which have led to considerable cost increases in the industry.

"In some areas there has been a significant shortage of materials, which in some cases made cost-intensive stock-building in the packaging industry necessary in order to ensure the delivery reliability of this system-relevant industry," says Johannes Schick, chairman of GDA’s tubes, cans and extruded parts division. “In this way, out-of-stock situations could also be avoided for the customers of the tube and can manufacturers. As in the entire crisis, the packaging industry has delivered in the truest sense of the word and has distinguished itself as a reliable partner in the supply chain even under the most difficult market conditions,” added Schick.

Overall, the outlook for the industry for the rest of 2021 is cautiously optimistic, despite the spreading delta variant and a decreasing willingness to vaccinate. The brightening mood and confidence in the population should fuel consumption in the next few months, so that in 2021 at least the result of last year could be achieved.
 

As the company explained, its latest series is certified as ethically sourced by the Rainforest Alliance, and sourced